The government panel on Friday approved the marketing authorisation of Covishield, the vaccine candidate of Serum Institute of India, for emergency use in India, say media reports.

โ€œThe Subject Expert Committee has recommended in favour of marketing authoritsation to SIIโ€™s vaccine but with certain conditions,โ€ a media report by The Economic Times quoted a person, who is aware of the matter, as saying.

Ready for a challenge? Click here to take our quiz and show off your knowledge!

The central government formed a subject expert committee which was given the tasks of vetting Covid19 vaccine proposals.

As per a report in CNBCTV18, the recommendation comes with certain conditions but it didnโ€™t elaborate on them.

The Serum Institute of India has already manufactured 7.5 crore doses of Covishield and 4 crore doses are ready for delivery.

Ready for a challenge? Click here to take our quiz and show off your knowledge!

A report in India Today said the Drug Controller General of India (DGCI) will take a final call on whether or not to approve the vaccine for emergency usage authorisation.